Genetic ablation of either G6P-isomerase or dual LDHA/B in colon cancer cells LS174T , +/- MPP+ (1-methyl-4-phenylpyridinium)
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE149289
下载链接
链接失效反馈官方服务：
资源简介：
In this study we explore the genomic re-wiring of a human colon cancer cell line (LS174T) in which fermentative glycolysis has been fully suppressed by CRISPR/Cas9 to disrupt glucose-6-phosphate isomerase (GPI-KO) or dual disruption of lactate dehydrogenases A and B (LDHAB-DKO). The effects of both KOs, had no effect on loss of viable cell function, corresponding to high concentrations of ATP production vs WT. All three clones were evaluated for transcriptomic changes using GeneChip™ Human Gene 2.1 ST Arrays by Affymetrix Inc assessing for mRNAs and long intergenic non-coding RNA transcripts. Six conditions: LS174T Colon Cancer Vector Control LS174T Colon Cancer LDHAB Double Knock Out LS174T Colon Cancer G6PI Knock Out LS174T Colon Cancer Vector Control + MPP+ LS174T Colon Cancer LDHAB Double Knock Out + MPP+ LS174T Colon Cancer G6PI Knock Out + MPP+
创建时间：
2021-11-09
